AUDUBON, Pa., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2015.
* Worldwide sales increased 16.3% to $137.0 million, or 17.6% on a constant currency basis
* Third quarter net income increased 14.8% to $26.5 million, or 18.0% on a constant currency basis
* Fully diluted earnings per share (EPS) were $0.28
* Non-GAAP Adjusted EBITDA was 36.9% of sales
* Company increases 2015 guidance for sales to $539 million and EPS to $1.07
Help employers find you! Check out all the jobs and post your resume.
